NCT06472830
MGUS/MM Awareness and Genetics Insights Campaign (MAGIC) Screening Study
Enrolling by Invitation
Not specifiedAges 40+ObservationalMayo ClinicInvestigator-initiated
~1,000 participants
Updated 2026-03-30 on ClinicalTrials.gov
What's tested:Non-Interventional Study
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Prevalence of monoclonal gammopathies across ancestrally diverse populations
Measured over Up to 10 years
Conditions
Where it's being run
1 sites across 1 statesMinnesota1
Study leadership
- Joselle M. Cook, M.B.B.S. · PRINCIPAL_INVESTIGATOR · Mayo Clinic in Rochester
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Adults ≥ 40 years
Willing and able to review, understand, and provide consent before starting any study-specific procedures
Ability to complete questionnaire(s) by themselves or with assistance
Exclusion
Pregnant women
What this trial measures
- Prevalence of monoclonal gammopathies across ancestrally diverse populationsUp to 10 years
Screen for monoclonal gammopathies using mass spectrometry to detect monoclonal proteins among people across ancestrally diverse populations in Minnesota, with prespecified, ancestry-informed analyses within East African, West African, Afro-Caribbean, and Non-Hispanic White groups.